Variant report

Variant	nsv1042467
Chromosome Location	chr12:86017619-86078149
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:449)
CpG islands
(count:61)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:449 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:86036581-86037005	HepG2	liver:	n/a	n/a
2	BRCA1	chr12:86019903-86020631	Hela-S3	cervix:	n/a	n/a
3	CBX3	chr12:86020121-86020665	HCT-116	colon:	n/a	n/a
4	CEBPB	chr12:86027250-86027714	HCT-116	colon:	n/a	n/a
5	CEBPB	chr12:86036562-86036986	A549	lung:	n/a	chr12:86036746-86036757
6	CEBPB	chr12:86068530-86068730	A549	lung:	n/a	chr12:86068595-86068606
7	CEBPB	chr12:86021336-86021743	IMR90	lung:	n/a	n/a
8	CEBPB	chr12:86036609-86036880	HepG2	liver:	n/a	chr12:86036746-86036757
9	CEBPB	chr12:86036533-86037022	MCF-7	breast:	n/a	chr12:86036746-86036757
10	CEBPB	chr12:86052095-86052295	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr12:86036576-86036938	A549	lung:	n/a	chr12:86036746-86036757
12	CEBPB	chr12:86020186-86020596	A549	lung:	n/a	n/a
13	CEBPB	chr12:86036541-86036964	HepG2	liver:	n/a	chr12:86036746-86036757
14	CEBPB	chr12:86036542-86036989	Hela-S3	cervix:	n/a	chr12:86036746-86036757
15	CEBPB	chr12:86036545-86036953	IMR90	lung:	n/a	chr12:86036746-86036757
16	CEBPB	chr12:86020007-86020716	HCT-116	colon:	n/a	chr12:86020651-86020662
17	CEBPB	chr12:86036462-86037083	HCT-116	colon:	n/a	chr12:86036746-86036757
18	CEBPB	chr12:86019722-86020633	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr12:86036563-86036936	MCF-7	breast:	n/a	chr12:86036746-86036757
20	CEBPB	chr12:86020204-86020533	A549	lung:	n/a	n/a
21	CEBPB	chr12:86052168-86052249	K562	blood:	n/a	n/a
22	CEBPB	chr12:86032813-86033108	HepG2	liver:	n/a	chr12:86033071-86033083
23	CEBPB	chr12:86068448-86068731	HepG2	liver:	n/a	chr12:86068595-86068606
24	CEBPB	chr12:86036618-86036904	HepG2	liver:	n/a	chr12:86036746-86036757
25	CEBPB	chr12:86028843-86029069	HepG2	liver:	n/a	n/a
26	CEBPB	chr12:86060080-86060137	HepG2	liver:	n/a	n/a
27	CEBPB	chr12:86019830-86021039	IMR90	lung:	n/a	chr12:86020651-86020662
28	CEBPB	chr12:86068475-86068698	IMR90	lung:	n/a	chr12:86068595-86068606
29	CEBPB	chr12:86036559-86036960	HepG2	liver:	n/a	chr12:86036746-86036757
30	CEBPB	chr12:86020105-86020665	HCT-116	colon:	n/a	chr12:86020651-86020662
31	CEBPB	chr12:86020158-86020619	A549	lung:	n/a	n/a
32	CEBPB	chr12:86036612-86036933	H1-hESC	embryonic stem cell:	n/a	chr12:86036746-86036757
33	CEBPB	chr12:86021300-86021775	Hela-S3	cervix:	n/a	n/a
34	CEBPD	chr12:86036667-86036892	HepG2	liver:	n/a	chr12:86036747-86036758
35	CEBPD	chr12:86036657-86036867	HepG2	liver:	n/a	chr12:86036747-86036758
36	CHD2	chr12:86020187-86020626	Hela-S3	cervix:	n/a	n/a
37	CHD2	chr12:86036616-86036939	HepG2	liver:	n/a	n/a
38	CTCF	chr12:86036618-86037032	HCT-116	colon:	n/a	n/a
39	CTCF	chr12:86036780-86036930	AG04450	lung:	n/a	n/a
40	CTCF	chr12:86036699-86036920	MCF-7	breast:	n/a	n/a
41	CTCF	chr12:86036800-86036950	Hela-S3	cervix:	n/a	n/a
42	CTCF	chr12:86036700-86036850	NHEK	skin:	n/a	n/a
43	CTCF	chr12:86036680-86036830	HFF	foreskin:	n/a	n/a
44	CTCF	chr12:86020667-86020758	Lung_OC	lung:	n/a	n/a
45	CTCF	chr12:86036780-86036930	RPTEC	kidney:	n/a	n/a
46	CTCF	chr12:86036760-86036910	NHDF-neo	bronchial:	n/a	n/a
47	CTCF	chr12:86036740-86036890	GM12865	blood:	n/a	n/a
48	CTCF	chr12:86036800-86036950	HA-sp	spinal cord:	n/a	n/a
49	CTCF	chr12:86043834-86043861	GM10248	blood:	n/a	n/a
50	CTCF	chr12:86036840-86036990	HFF-Myc	foreskin:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:86040467-86040517	PFSK-1	brain:	n/a
2	chr12:86040467-86040517	Hepatocyte	liver:	n/a
3	chr12:86040467-86040517	AG04450	lung:	fetal
4	chr12:86040467-86040517	NB4	blood:	n/a
5	chr12:86040467-86040517	ProgFib	skin:	n/a
6	chr12:86040467-86040517	NHBE	bronchial:	n/a
7	chr12:86040467-86040517	HRCEpiC	kidney:	n/a
8	chr12:86040467-86040517	GM12891	blood:	n/a
9	chr12:86040467-86040517	AG04449	skin:	fetal
10	chr12:86040467-86040517	Jurkat	blood:	n/a
11	chr12:86040467-86040517	BE2_C	brain:	n/a
12	chr12:86040467-86040517	U87	brain:	n/a
13	chr12:86040467-86040517	NT2-D1	testis:	n/a
14	chr12:86040467-86040517	CMK	blood:	n/a
15	chr12:86040467-86040517	PANC-1	pancreas:	n/a
16	chr12:86040467-86040517	NHDF-neo	bronchial:	n/a
17	chr12:86040467-86040517	AG09309	skin:	n/a
18	chr12:86040467-86040517	HCPEpiC	choroid plexus:	n/a
19	chr12:86040467-86040517	HEK293	kidney:	embryo
20	chr12:86040467-86040517	HRE	kidney:	n/a
21	chr12:86040467-86040517	SK-N-SH	brain:	n/a
22	chr12:86040467-86040517	HCF	heart:	n/a
23	chr12:86040467-86040517	A549	lung:	n/a
24	chr12:86040467-86040517	SK-N-MC	brain:	n/a
25	chr12:86040467-86040517	MCF10A-Er-Src	breast:	n/a
26	chr12:86040467-86040517	HNPCEpiC	eye:	n/a
27	chr12:86040467-86040517	ECC-1	luminal epithelium:	n/a
28	chr12:86040467-86040517	HCM	heart:	n/a
29	chr12:86040467-86040517	HL-60	blood:	n/a
30	chr12:86040467-86040517	IMR90	lung:	fetal
31	chr12:86040467-86040517	GM12892	blood:	n/a
32	chr12:86040467-86040517	HIPEpiC	eye:	n/a
33	chr12:86040467-86040517	HMEC	breast:	n/a
34	chr12:86040467-86040517	MCF-7	breast:	n/a
35	chr12:86040467-86040517	HPAEpiC	pulmonary alveolar:	n/a
36	chr12:86040467-86040517	AG09319	gingival:	n/a
37	chr12:86040467-86040517	SAEC	small airway:	n/a
38	chr12:86040467-86040517	ovcar-3	ovarian:	n/a
39	chr12:86040467-86040517	HAEpiC	amniotic membrane:	n/a
40	chr12:86040467-86040517	AoSMC	blood vessel:	n/a
41	chr12:86040467-86040517	Caco-2	colon:	n/a
42	chr12:86040467-86040517	GM06990	blood:	n/a
43	chr12:86040467-86040517	HCT-116	colon:	n/a
44	chr12:86040467-86040517	T-47D	breast:	n/a
45	chr12:86040467-86040517	RPTEC	kidney:	n/a
46	chr12:86040467-86040517	K562	blood:	n/a
47	chr12:86040467-86040517	HepG2	liver:	n/a
48	chr12:86040467-86040517	GM19239	blood:	n/a
49	chr12:86040467-86040517	AG10803	skin:	n/a
50	chr12:86040467-86040517	H1-hESC	embryonic stem cell:	embryo

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:85969213..85970141-chr12:86036344..86037184,4	MCF-7	breast:
2	chr12:86039752..86042569-chr12:86049192..86051489,2	MCF-7	breast:
3	chr12:86014804..86017595-chr12:86018520..86021053,2	MCF-7	breast:
4	chr12:86036224..86038282-chr12:86040678..86042966,2	MCF-7	breast:
5	chr12:86031568..86033990-chr12:86035290..86037133,2	K562	blood:
6	chr12:86031568..86033990-chr12:86035290..86037133,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000263449	TF binding region
ENSG00000263449	CpG island
ENSG00000263449	chromatin interactions

Extended variants
information (count: 1393 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1393 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2405254	chr12:86017619-86017620	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs564757983	chr12:86017645-86017646	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs111644771	chr12:86017646-86017647	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs370358801	chr12:86017706-86017707	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs140994418	chr12:86017733-86017734	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs550643105	chr12:86017735-86017736	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs557587808	chr12:86017773-86017774	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs561953761	chr12:86017824-86017825	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs569142134	chr12:86017841-86017842	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs529794237	chr12:86017876-86017877	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs374386459	chr12:86017944-86017945	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs548005735	chr12:86018040-86018041	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs554795774	chr12:86018050-86018051	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs150215995	chr12:86018058-86018059	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs112820529	chr12:86018079-86018080	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs192855513	chr12:86018091-86018092	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs566593833	chr12:86018109-86018110	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs544298888	chr12:86018120-86018121	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs77700940	chr12:86018121-86018122	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs531087225	chr12:86018127-86018128	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs534062634	chr12:86018167-86018168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs34034095	chr12:86018175-86018176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs558505528	chr12:86018182-86018183	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs546411146	chr12:86018190-86018191	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs564846726	chr12:86018195-86018196	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs376113765	chr12:86018213-86018214	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs528759873	chr12:86018274-86018275	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs547005419	chr12:86018313-86018314	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs568328042	chr12:86018324-86018325	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs147941917	chr12:86018330-86018331	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs35342467	chr12:86018411-86018412	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs562954350	chr12:86018418-86018419	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs374636544	chr12:86018420-86018421	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs3040635	chr12:86018421-86018422	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs184834657	chr12:86018491-86018492	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs11116934	chr12:86018518-86018519	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs71443591	chr12:86018530-86018531	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs11116935	chr12:86018532-86018533	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs189391754	chr12:86018601-86018602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs533814409	chr12:86018632-86018633	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs555365215	chr12:86018642-86018643	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs35709579	chr12:86018643-86018644	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs575080397	chr12:86018644-86018645	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs77303101	chr12:86018688-86018689	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs537949494	chr12:86018708-86018709	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs191393159	chr12:86018724-86018725	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs202247538	chr12:86018749-86018750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs184697591	chr12:86018834-86018835	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs546448258	chr12:86018894-86018895	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs34749348	chr12:86018908-86018909	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17899364	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	22032731	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Renal cell carcinoma	18194544	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD

Chromatin state (count:138 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:86015200-86020400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr12:86015600-86019600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
3	chr12:86015600-86019600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
4	chr12:86015600-86019600	Weak transcription	HMEC	breast
5	chr12:86015600-86019800	Weak transcription	NHEK	skin
6	chr12:86017000-86017800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr12:86017200-86018600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr12:86017400-86018000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr12:86018400-86022000	Enhancers	Hela-S3	cervix
10	chr12:86018600-86019800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr12:86019000-86019800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr12:86019000-86022000	Enhancers	HUVEC	blood vessel
13	chr12:86019200-86021200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
14	chr12:86019400-86020000	Enhancers	Muscle Satellite Cultured Cells	--
15	chr12:86019400-86021800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr12:86019600-86020800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr12:86019600-86021000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr12:86019600-86021400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr12:86019600-86021600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr12:86019600-86021800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr12:86019600-86021800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr12:86019600-86021800	Enhancers	HMEC	breast
23	chr12:86019600-86021800	Enhancers	HSMM	muscle
24	chr12:86019600-86021800	Enhancers	NH-A	brain
25	chr12:86019600-86021800	Enhancers	NHDF-Ad	bronchial
26	chr12:86019600-86021800	Enhancers	NHLF	lung
27	chr12:86019600-86022000	Enhancers	Osteobl	bone
28	chr12:86019800-86020000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr12:86019800-86020200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr12:86019800-86020400	Enhancers	NHEK	skin
31	chr12:86019800-86020800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
32	chr12:86019800-86021200	Enhancers	Primary hematopoietic stem cells	blood
33	chr12:86019800-86021600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr12:86019800-86021800	Enhancers	Primary hematopoietic stem cells short term culture	blood
35	chr12:86020000-86020200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
36	chr12:86020200-86020400	Enhancers	Muscle Satellite Cultured Cells	--
37	chr12:86020200-86021600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr12:86020400-86020600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
39	chr12:86020400-86020800	Flanking Active TSS	NHEK	skin
40	chr12:86020400-86021000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr12:86020400-86021800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr12:86020400-86021800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr12:86020600-86022000	Enhancers	Muscle Satellite Cultured Cells	--
44	chr12:86020800-86022000	Enhancers	NHEK	skin
45	chr12:86021000-86024000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr12:86021600-86024400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr12:86021600-86026200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr12:86021800-86025800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr12:86021800-86025800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr12:86021800-86026000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links